Biomedical Imaging

Biomedical Imaging

Extract more from images
to drive Drug Discovery with AI

Throughout many years, information contained in images was underappreciated and unused due to the limitations of human capabilities. However, thanks to recent breakthroughs and our own expertise in Computer Vision and Biomedical Image Analysis, we are able to guide you through the effective analysis of vast amounts of images, which are an especially rich source of information.

Our Technology Platform for Biomedical Imaging, provides you with reliable and interpretable AI models, for both clinical and preclinical usage.

Overcome your challenges in biomedical image analysis to unlock insights from your experiments

Biomedical image analysis

Biomedical images are helpful sources for scientists and practitioners in drawing significant hypotheses, exemplifying approaches, and describing experimental results. It is one of the highly complex and unaccomplished tasks scientists and physicians face today when it comes to implementing a system, which can help them collect, curate, annotate and validate information distributed among biological images.

There has been a significant increase in the amount of heterogeneous biomedical image generation, which results in a need for bioimaging platforms for feature extraction and analysis. This could give an advantage in implementing effective information retrieval systems.

It’s not easy to leverage full information from images. We provide Computer Vision solutions to many clients that are struggling with various difficulties. Some of them were related to:

Are you facing similar challenges?

TEESTOWY TYTUŁ

TESTOWY OPIS NOWO UTWORZONEJ SEKCJI

abc

Value we deliver

Pierwszy testowy punkt
Drugi testowy punkt
Trzeci testowy punkt
Czwarty testowy punkt
Piąty testowy punkt

Discovery and clinical phase

Digital histopathology

Accelerated learning to reveal more from your biopsy results

Our platform enables you to process whole-slide biopsy images in a scalable manner, without any loss of information contained in the image and with instant quality check and image standardization. Moreover, it highlights areas that contain pathological changes and performs automatic segmentation of the tissue. This process can be applied to various scoring systems, such as the Nancy and Geboes Histological score (for inflammatory bowel disease data) or the Gleason score (for prostate cancer data).

Problem
definition

Value we deliver

leveraging expertise of histopathologists
meaningful and interpretable predictions
proven performance comparable to an expert pathologist
automatic detection of quality flaws
more reliable and precise diagnostics

Discovery phase

High content screening analysis

Image based virtual screening to increase the chance for success of your drug candidate

Our platform solves the challenges of a vast number of image analyses by providing modular deep learning pipelines that generate image based compound descriptors, predict selected molecular properties and activities towards selected targets and automatically retrain to fit newly generated data. It also identifies the drug and drug targets that modulate specific phenotypes. High Content Phenotypic Screening aims to identify morphological patterns in cell populations and to probe the causes and cures for various diseases.

Problem
definition

Value we deliver

acceleration of the drug discovery process
improved accuracy
meaningful and interpretable prediction
automatic detection of quality flaws

Discovery phase

Microarrays

An automated and more reliable process for your custom microarray analysis

Microarray technology has gained momentum in the drug and biomarker discovery fields. Extracting information from microarrays requires precision and reliability, and our microarray analysis system delivers it all. It performs quality checks and applies image correction techniques, such as distortion correction or flat-field correction. It also finds the grid of features on the array and extracts their pixel intensities, creating automatic segmentation of regions of interest. Additionally, the system can be deployed in the cloud and easily integrated into the already existing analytic pipelines.

Problem
definition

Value we deliver

fully automated data acquisition
integrated microarray image quality check
more reliable process of microarray usage
improved statistical properties of the platform
FDA-compliant process & documentation

Technology Platform for Biomedical Imaging

The Ardigen platform is applying various algorithms, deep neural networks and machine learning techniques for analyzing biomedical images to help scientists and physicians understand and predict the behavior of complex biological systems.

We strive to improve accuracy and efficiency of diagnostic and therapeutic procedures by utilizing our biomedical computing competences such as: digital image acquisition, processing, quantitative analysis and artificial intelligence in biomedicine; as well as human-computer-interaction and user experience engineering.

Our science

We are driven by science and collaborations!

Since 2015, we’ve had the opportunity to execute a variety of exciting and complex projects, both for our clients and internally.
A high degree of trust and confidentiality is the foundation for our business. That’s why we are always very excited to share the results of our scientific projects.
We publish and present materials, such as journal publications, posters, case studies and technical notes whenever possible, through which we aim to show the scope of our scientific team’s experience.

On demand webinars

6 December 2022 Leveraging Single-Cell Transcriptomics for the Discovery of New Therapeutic

22 October 2022 Latest developments in the Nextflow ecosystem – Reproducible omics pipelines in a cloudy world

30 August 2022 Webinar: Computer Vision for Precision Medicine

Meet us at upcoming events

Coming soon

24 - 25 May 2023

Brussels, Belgium

SLAS Europe
25 February - 1 March 2023

San Diego, USA

SLAS
25 - 27 January 2023

Santa Clara, USA

PMWC
24 - 25 October 2022

Wroclaw, Poland

Central European Technology Forum
4 - 5 October 2022

UK, London

ELRIG 2022
18 - 20 September 2022

Boston, USA

SBI2
26 -28 June

PMWC 2022
15-16 February 2022

digital

Boost your way to successful therapy. AI for Drug Discovery Days”
23 - 26 June

digital

SLAS Europe 2021
14 - 18 June

digital

PMWC 2021 COVID Virtual
15 - 17 June

digital

Pharma R&D Week Virtual
9-10 June

digital

Precision in Drug Discovery & Preclinical Virtual Summit
17 - 19 May 2021

Biomarkers Week
14 April

digital

Spatial Biology Europe conference
25 - 26 March

digital

AI in Healthcare & Pharma Virtual Summit

Biomedical Imaging

Overcome your challenges in biomedical image analysis to unlock insights from your experiments